Followers | 149 |
Posts | 17898 |
Boards Moderated | 0 |
Alias Born | 04/12/2012 |
Monday, February 24, 2014 11:28:13 AM
10:20 AM EST, 02/24/2014 (MT Newswires) -- Sunlink Health Systems (SSY) was up more than 12% in early trade after saying it has adopted a new shareholder rights plan intended to "encourage fair treatment of shareholders should a take-over bid be made" for the company.
The operator of hospitals and related businesses said the plan will only come into effect if someone acquires, or announces its intention to acquire, 20% or more of the company's shares. If that happens, a rights holder will be entitled to buy shares at "a substantial discount" to the market price at the time. The company didn't provide details as to the size of the discount. Nor did it say if there was any indication that a buyer was looking at the company.
The stock recently traded at $1.32, off its session high so far of $1.39, in a 52-week range of $0.51 - $1.88.
Price: 1.32, Change: +0.15, Percent Change: +12.5
http://www.mtnewswires.com © 2014 MT Newswires, a Division of MidnightTrader, Inc. All rights reserved.
IMO
Recent SSY News
- SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results • Business Wire • 02/13/2024 11:12:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:54:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 06:39:01 PM
- Sunlink Health Systems’ Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics • Business Wire • 01/29/2024 02:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 08:17:31 PM
- SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center • Business Wire • 12/12/2023 02:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 08:17:47 PM
- SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results • Business Wire • 11/20/2023 02:14:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:09:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:20:32 PM
- Micro Cap Bid Up Following Asset Sale Announcement • AllPennyStocks.com • 11/14/2023 02:25:00 PM
- SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center • Business Wire • 11/13/2023 10:42:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/13/2023 10:26:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:37:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:22:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 06:56:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 06:49:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 06:41:32 PM
- SunLink Health Systems, Inc. Announces Fiscal 2023 Fourth Quarter and Annual Results • Business Wire • 09/28/2023 08:02:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 03:41:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/27/2023 05:11:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 09:40:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 09:17:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 09:09:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM